US9604131022 - Common Stock

Overall **WLK** gets a fundamental rating of **4** out of 10. We evaluated **WLK** against 84 industry peers in the **Chemicals** industry. **WLK** has only an average score on both its financial health and profitability. **WLK** is valued expensive and it does not seem to be growing.

Each year in the past 5 years **WLK** has been profitable.

In the past 5 years **WLK** always reported a positive cash flow from operatings.

The **Return On Assets** of **WLK** (**1.23%**) is comparable to the rest of the industry.

Looking at the **Return On Equity**, with a value of **2.49%**, **WLK** is in line with its industry, outperforming **44.05%** of the companies in the same industry.

The 3 year average ROIC (**10.46%**) for **WLK** is well above the current ROIC(**3.83%**). The reason for the recent decline needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 1.23% | ||

ROE | 2.49% | ||

ROIC | 3.83% |

ROA(3y)8%

ROA(5y)5.91%

ROE(3y)17.45%

ROE(5y)12.99%

ROIC(3y)10.46%

ROIC(5y)7.72%

The **Gross Margin** of **WLK** (**15.56%**) is worse than **70.24%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 7.56% | ||

PM (TTM) | 2.11% | ||

GM | 15.56% |

OM growth 3Y16.58%

OM growth 5Y-10.07%

PM growth 3Y-4.71%

PM growth 5Y-19.86%

GM growth 3Y9.06%

GM growth 5Y-5.13%

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **WLK** is still creating some value.

The number of shares outstanding for **WLK** has been increased compared to 1 year ago.

The number of shares outstanding for **WLK** remains at a similar level compared to 5 years ago.

Compared to 1 year ago, **WLK** has an improved debt to assets ratio.

An Altman-Z score of **2.77** indicates that **WLK** is not a great score, but indicates only limited risk for bankruptcy at the moment.

With a decent **Debt to FCF ratio** value of **5.13**, **WLK** is doing good in the industry, outperforming **67.86%** of the companies in the same industry.

A Debt/Equity ratio of **0.44** indicates that **WLK** is not too dependend on debt financing.

The **Debt to Equity ratio** of **WLK** (**0.44**) is better than **61.90%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.44 | ||

Debt/FCF | 5.13 | ||

Altman-Z | 2.77 |

ROIC/WACC0.49

WACC7.87%

A Quick Ratio of **1.83** indicates that **WLK** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.46 | ||

Quick Ratio | 1.83 |

The earnings per share for **WLK** have decreased strongly by **-54.97%** in the last year.

The **Earnings Per Share** has been growing slightly by **1.36%** on average over the past years.

The **Revenue** has been growing slightly by **7.76%** on average over the past years.

EPS 1Y (TTM)-54.97%

EPS 3Y53.93%

EPS 5Y1.36%

EPS Q2Q%-56.07%

Revenue 1Y (TTM)-19.39%

Revenue growth 3Y18.69%

Revenue growth 5Y7.76%

Sales Q2Q%-11.35%

Based on estimates for the next years, **WLK** will show a small growth in **Revenue**. The Revenue will grow by **4.22%** on average per year.

EPS Next Y-12.94%

EPS Next 2Y4.6%

EPS Next 3Y9.06%

EPS Next 5YN/A

Revenue Next Year-1.38%

Revenue Next 2Y3.08%

Revenue Next 3Y4.22%

Revenue Next 5YN/A

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

A **Price/Earnings** ratio of **24.10** indicates a rather expensive valuation of **WLK**.

Based on the **Price/Forward Earnings** ratio of **17.48**, the valuation of **WLK** can be described as rather expensive.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **WLK** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 24.1 | ||

Fwd PE | 17.48 |

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **WLK**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 21.34 | ||

EV/EBITDA | 10.84 |

PEG (NY)N/A

PEG (5Y)17.75

EPS Next 2Y4.6%

EPS Next 3Y9.06%

Compared to an average industry **Dividend Yield** of **3.11**, **WLK** has a dividend in line with its industry peers.

With a **Dividend Yield** of **1.28**, **WLK** pays less dividend than the S&P500 average, which is at **2.37**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.28% |

On average, the dividend of **WLK** grows each year by **13.11%**, which is quite nice.

Dividend Growth(5Y)13.11%

Div Incr Years10

Div Non Decr Years10

DP93%

EPS Next 2Y4.6%

EPS Next 3Y9.06%

**WESTLAKE CORP**

NYSE:WLK (5/30/2024, 10:26:08 AM)

**158.345**

**+1.63 (+1.04%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap20.36B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.28% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 24.1 | ||

Fwd PE | 17.48 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)17.75

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 1.23% | ||

ROE | 2.49% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 7.56% | ||

PM (TTM) | 2.11% | ||

GM | 15.56% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.58

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.44 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.46 | ||

Quick Ratio | 1.83 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-54.97%

EPS 3Y53.93%

EPS 5Y

EPS Q2Q%

EPS Next Y-12.94%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-19.39%

Revenue growth 3Y18.69%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y